118 related articles for article (PubMed ID: 10828836)
21. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer.
Chan CM; Lykkesfeldt AE; Parker MG; Dowsett M
Clin Cancer Res; 1999 Nov; 5(11):3460-7. PubMed ID: 10589759
[TBL] [Abstract][Full Text] [Related]
22. Multiplex semi-quantitative reverse transcriptase-polymerase chain reaction of low abundance neuronal mRNAs.
Pernas-Alonso R; Morelli F; di Porzio U; Perrone-Capano C
Brain Res Brain Res Protoc; 1999 Dec; 4(3):395-406. PubMed ID: 10592350
[TBL] [Abstract][Full Text] [Related]
23. Ligand-independent activation of estrogen receptor alpha by XBP-1.
Ding L; Yan J; Zhu J; Zhong H; Lu Q; Wang Z; Huang C; Ye Q
Nucleic Acids Res; 2003 Sep; 31(18):5266-74. PubMed ID: 12954762
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
25. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
26. Selection of HPRT primers as controls for determination of mRNA expression in dogs by RT-PCR.
Johnson CM; Yang S; Sellins KS; Frank GR
Vet Immunol Immunopathol; 2004 May; 99(1-2):47-51. PubMed ID: 15113653
[TBL] [Abstract][Full Text] [Related]
27. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
[TBL] [Abstract][Full Text] [Related]
28. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
29. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
30. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
[TBL] [Abstract][Full Text] [Related]
31. Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.
Martinez de Arrieta C; Koibuchi N; Chin WW
Endocrinology; 2000 May; 141(5):1693-8. PubMed ID: 10803578
[TBL] [Abstract][Full Text] [Related]
32. Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.
Monroe DG; Johnsen SA; Subramaniam M; Getz BJ; Khosla S; Riggs BL; Spelsberg TC
J Endocrinol; 2003 Mar; 176(3):349-57. PubMed ID: 12630920
[TBL] [Abstract][Full Text] [Related]
33. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
34. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
35. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression.
Cavallini A; Notarnicola M; Giannini R; Montemurro S; Lorusso D; Visconti A; Minervini F; Caruso MG
Eur J Cancer; 2005 Jul; 41(10):1487-94. PubMed ID: 15949936
[TBL] [Abstract][Full Text] [Related]
36. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
37. Expression of estrogen receptor coactivators in the rat uterus.
Nephew KP; Ray S; Hlaing M; Ahluwalia A; Wu SD; Long X; Hyder SM; Bigsby RM
Biol Reprod; 2000 Aug; 63(2):361-7. PubMed ID: 10906038
[TBL] [Abstract][Full Text] [Related]
38. Putative estrogen receptor beta and alpha mRNA expression in male and female rhesus macaques.
Pau CY; Pau KY; Spies HG
Mol Cell Endocrinol; 1998 Nov; 146(1-2):59-68. PubMed ID: 10022763
[TBL] [Abstract][Full Text] [Related]
39. Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation.
Wieser F; Schneeberger C; Hudelist G; Singer C; Kurz C; Nagele F; Gruber C; Huber JC; Tschugguel W
Mol Hum Reprod; 2002 Jul; 8(7):644-50. PubMed ID: 12087079
[TBL] [Abstract][Full Text] [Related]
40. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
